HUM
HumanaPrevious close
384.72
Change
−11.90 / −3.00%
52-Week Range
163.11 – 428.88
P/E (TTM)
36.0
Forward P/E
27.7
Based on consensus earnings for the next 12 months
Market Cap
$46.2B
1M
+0.11%
S&P 500 −2.41% over same period
Volume / Avg Volume
1.0M / 863K
1.20× average
Recent Earnings
Click to read the FinDog analysis| Period | Reported | Revenue | EPS Actual / Est. | Analysis |
|---|---|---|---|---|
| FY2026 Q2 Quarter ended 2026-06 | 2026-07-29 | $40.9B | 7.61 / 7.29 | Pending |
| FY2026 Q1 Quarter ended 2026-03 | 2026-04-29 | $39.6B | 10.31 / 10.29 | Pending |
| FY2025 Q4 Quarter ended 2025-12 | 2026-02-11 | — | — / — | Pending |
| FY2025 Q3 Quarter ended 2025-09 | 2025-11-05 | — | — / — | Pending |
| FY2025 Q2 Quarter ended 2025-06 | 2025-07-30 | — | — / — | Pending |
| FY2025 Q1 Quarter ended 2025-03 | 2025-04-30 | — | — / — | Pending |
Decision Panel
Trends · Valuation · Earnings reaction · Guidance credibility — all from company filings and market dataValuation
P/E is at percentile 91 of its 5-year rangeExpensive
5-year range 16.0 – 41.0 · Median 20.9
Last 4 quarters: $249M in buybacks + $429M in dividends, 1.47% of market cap combined
P/E (TTM)
36.0
P/B
2.4
P/S
0.3
Dividend Yield
0.68%
Earnings Reaction
Over the last 6 reports, the stock moved ±2.8% on average on the first trading day after, rising 2 times
Most recent +0.34%
Volatility & Correlation
1-year beta 0.56 · Correlation with S&P 500 0.15Low beta
Annualized volatility 47% vs. 13% for the S&P 500
Insider Trading
View all →Last 90 days · Open-market buys and sells by officers and directors · Amounts in USD millions
No open-market buys or sells by officers or directors in the last 90 days.
Multi-Quarter Financial Trends
View all quarters →Last 12 quarters · As reported by the company
| Quarter | Revenue ($B) | YoY | Gross Margin | Net Income ($B) | EPS |
|---|---|---|---|---|---|
| FY2026 Q1 | 39.65 | +23.5% | — | 1.19 | 9.83 |
| FY2025 Q4 | 32.52 | +11.3% | — | -0.80 | -6.59 |
| FY2025 Q3 | 32.65 | +11.1% | — | 0.20 | 1.62 |
| FY2025 Q2 | 32.39 | +9.6% | — | 0.55 | 4.51 |
| FY2025 Q1 | 32.11 | +8.4% | — | 1.24 | 10.30 |
| FY2024 Q4 | 29.21 | +10.4% | — | -0.69 | -5.73 |
| FY2024 Q3 | 29.40 | +11.3% | — | 0.48 | 3.98 |
| FY2024 Q2 | 29.54 | +10.4% | — | 0.68 | 5.62 |
| FY2024 Q1 | 29.61 | +10.7% | — | 0.74 | 6.11 |
| FY2023 Q4 | 26.46 | +17.9% | — | -0.54 | -4.24 |
| FY2023 Q3 | 26.42 | +15.9% | — | 0.83 | 6.71 |
| FY2023 Q2 | 26.75 | +13.0% | — | 0.96 | 7.66 |
| Ticker | P/E | Revenue YoY | Gross Margin | 1M | View |
|---|---|---|---|---|---|
| HUM | 36.0 | +23.5% | — | +0.11% | Neutral |
| LLY | 39.9 | +47.7% | 85.8% | −3.83% | Bullish |
| JNJ | 30.6 | +6.6% | 68.2% | +1.87% | Bullish |
| ABBV | 73.7 | +10.2% | 74.7% | +4.87% | Neutral |
| MRK | 112.2 | +5.1% | 73.5% | +6.57% | Neutral |
| UNH | 23.9 | +0.4% | 88.1% | −5.15% | Neutral |
| TMO | 34.4 | +10.5% | — | +10.75% | Bullish |
| AMGN | 23.3 | +9.5% | 72.0% | −10.26% | Neutral |
| GILD | — | +10.2% | 79.8% | +6.31% | Neutral |